Comparison between Integra Essentia Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Integra Essentia Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024. Integra Essentia Rights Issue 2024 is listed on BSE, NSE while Solara Active Pharma Sciences Rights Issue 2024 is listed on BSE, NSE.
| Integra Essentia Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Logo |  |  |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | As per Terms of Payment : Issue Price - Fully payable on Application | Issue Price of Rs.375/- per share is payable as Rs.131.25 per share on Application. The remaining amount will be called within 24 months from the date of allotment in the Issue or within such extended period as may be determined by the Board or Rights Issue Committee of the Company at its sole discretion from time to time. |
| Entitlement | 20 Rights Equity Share(s) for every 119 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Lead Managers | Novus Capital Advisors Pvt.Ltd. | Choice Capital Advisors Pvt.Ltd. |
The issue size of Integra Essentia Rights Issue 2024 rights issue is ₹49.93 Crores, whereas Solara Active Pharma Sciences Rights Issue 2024 rights issue size is ₹449.95 Crores.
| Integra Essentia Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Issue Size | 15,36,24,538 shares | 1,19,98,755 shares |
| Issue Size (Amount) | ₹49.93 Crores | ₹449.95 Crores |
| Issue Price | ₹3.25 per share | ₹375 per share |
| Face Value | ₹1 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of Integra Essentia Rights Issue 2024 is Jun 01, 2024 while record date of Solara Active Pharma Sciences Rights Issue 2024 is May 15, 2024.
| Integra Essentia Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Record Date | Jun 01, 2024 | May 15, 2024 |
| Credit of Rights Entitlements | May 27, 2024 | |
| Bid/Offer Opens On | Jun 11, 2024 | May 28, 2024 |
| Renunciation of Rights Entitlements | Jun 20, 2024 | Jun 05, 2024 |
| Bid/Offer Closes On | Jun 25, 2024 | Jun 11, 2024 |
| Deemed Date of Allotment | Jul 29, 2024 | Jun 19, 2024 |
| Credit Date | Jul 02, 2024 | Jun 19, 2024 |
| Listing Date | Jul 05, 2024 | Jun 20, 2024 |
Comparison of Integra Essentia Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Integra Essentia Limited | Solara Active Pharma Sciences Ltd | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Integra Essentia Limited Financial Information (Restated Consolidated)Integra Essentia Limited's revenue increased by 257.83% and profit after tax (PAT) rose by 512.59% between the financial year ending with March 31, 2023 and March 31, 2022.
| Solara Active Pharma Sciences Ltd Financial Information (Restated Consolidated)Solara Active Pharma Sciences Ltd's revenue increased by 13.82% and profit after tax (PAT) rose by 61.85% between the financial year ending with March 31, 2023 and March 31, 2022.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
